The life sciences sector in the UK is experiencing an unprecedented boom, with investment reaching a record £4.5 billion last year. Positioned within the UK’s “golden triangle” alongside Oxford and Cambridge, London is a key player in this dynamic ecosystem, offering unique advantages for life sciences companies and investors. Amid this growth, one district stands out as the next focal point for innovation and collaboration: Bloomsbury.
A rich history of innovation
Bloomsbury’s heritage as a centre of scientific and medical advancement dates back to the 19th century, when it became home to pioneering institutions that laid the foundation for modern science. It was here that ecology and genetic science were born, establishing a legacy of intellectual excellence that continues to attract some of the world’s leading minds. Today, Bloomsbury is part of London’s Knowledge Quarter, a hub that includes renowned organisations such as the Wellcome Trust, the Francis Crick Institute, and the Alan Turing Institute.
The district’s rich history is intertwined with a future-facing commitment to progress, making it the ideal environment for life sciences companies seeking to bridge academia, industry, and cutting-edge research.
Addressing London’s chronic lab space shortage
London’s life sciences sector has, in recent years, been hampered by a chronic undersupply of laboratory space. Since 2016, the intense competition and high costs for premium facilities have forced many companies to seek alternatives outside the capital. However, this landscape is changing, as developers respond to growing demand with strategic investments in central locations.
One of the most significant projects driving this transformation is the redevelopment of Victoria House in Bloomsbury Square. A Grade II-listed building with a neoclassical façade, Victoria House is being transformed into 220,000 sq ft of state-of-the-art wet lab space, office facilities, and amenities. The project, spearheaded by Pioneer Group and Oxford Properties, aims to address the imbalance in lab supply by creating a best-in-class environment for life sciences companies at all stages of development.
Navigating slowdowns and sector resilience
While the life sciences sector continues to grow, recent shifts in investor sentiment have added a layer of complexity. The industry recently dropped to 11th in the ULI and PwC’s Emerging Trends Europe 2024 report, reflecting a slight cooling in venture capital funding. Yet, resilience remains a hallmark of the sector, with soaring demand for premium lab space driving rental prices in the golden triangle to new highs.
This resilience underscores the importance of careful, strategic development. The rush to convert office spaces into labs, while indicative of market enthusiasm, has raised concerns about oversupply and poorly suited properties entering the market. Against this backdrop, developments like Victoria House exemplify a more measured approach, delivering high-quality, well-positioned facilities that cater directly to the needs of life sciences innovators.
Victoria House: the epicentre of life sciences in London
Set to open in January 2025, Victoria House represents more than just a physical space. It is designed to be an ecosystem where life sciences start-ups, scale-ups, and established players can thrive. Within easy walking distance of world-class institutions such as University College London, GSK, and Great Ormond Street Hospital, its location facilitates collaboration between academia, healthcare, and industry.
The building’s seventh-floor incubator laboratories offer a flexible and adaptive environment for scientific entrepreneurs, featuring collaborative spaces and quiet zones tailored to the needs of early-stage companies. Moreover, with the BioIndustry Association (BIA) already signed on as its first life sciences tenant, Victoria House is poised to become a nucleus of innovation within the Knowledge Quarter.
The standout location for developers and tenants
Bloomsbury’s emergence as a life sciences hub aligns with broader trends in the UK’s innovation economy. Indeed, London has seen a 29% increase in life sciences employment since 2011, outpacing other regions and solidifying its position as a global leader. In addition, recent data from MedCity highlights a 7.1% growth in life sciences companies and an 8.4% rise in R&D sites across London, underscoring the sector’s vitality.
Bloomsbury is more than a location; it is a symbol of London’s potential to lead the global life sciences sector. With its unparalleled mix of history, connectivity, and cutting-edge facilities, the district offers a compelling proposition for companies, investors, and researchers.
Why Bloomsbury?
Bloomsbury is uniquely positioned to meet the growing demand for premium lab and office space; its central location, combined with a focus on quality and sustainability, makes it a standout option for developers and tenants.
As the UK continues to invest in the golden triangle’s unique strengths, Bloomsbury’s transformation into a life sciences hub will play a pivotal role in shaping the future of healthcare, biotechnology, and scientific discovery.
For those looking to be at the forefront of this next chapter in life sciences, Bloomsbury – with Victoria House as its centre piece – represents an unmissable opportunity.
Want to make Victoria House your home?
Be part of a thriving hub for world-class talent.